Florane

Quick links to important sections

Florane

Treatment option: Anesthesia, General Anesthesia

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Florane

Quick Facts about Florane

Property Description
Active ingredient Isoflurane
Form Liquid for Inhalation
Pharmacological class General Anesthetic
Common use Induction and maintenance of general anesthesia
Origin Synthetic Organic Compound

What is Florane and How is it Classified?

Florane is the trade name for the powerful medicinal agent Isoflurane, which is formally classified as a General Anesthetic. Its primary purpose is to rapidly induce and maintain a deep, controlled, and reversible state of unconsciousness, ensuring the patient is still and unaware during surgery. Isoflurane is specifically categorized as a volatile anesthetic agent, belonging to the chemical subclass of halogenated ethers, and is recognized as a synthetic organic compound. This classification highlights its mechanism as a potent Central Nervous System (CNS) depressant, a role supported by numerous pharmacological studies and clinically recognized for decades of use in anesthetic practice.


The Composition and Form of Florane

Florane is a single-agent product composed almost entirely of the active substance, Isoflurane (>99.9% purity), delivered as a clear, colorless liquid. The drug's physical form dictates its route of administration: it is classified as an inhalant and must be converted into a breathable vapor before use. A key differentiating factor for Isoflurane, compared to newer agents, is its distinct chemical stability and mild, yet noticeable, odor, characteristics well-known to anesthetic professionals. This composition and form allow the medical team to precisely regulate the necessary level of profound sedation throughout a procedure, such as major abdominal surgery.


What is the General Purpose of This Inhalational Anesthetic?

The general purpose of Florane is to facilitate the safe induction and maintenance of general anesthesia for patients undergoing surgical procedures. It achieves this goal through a principle often referred to as a Global Brain Slowdown, where the agent comprehensively reduces all electrical activity in the brain, leading to a rapid Consciousness Block. This mechanism is vital because it establishes the foundational medical requirement for invasive surgery: ensuring the patient remains unconscious, experiences no pain awareness, and is physically still, allowing surgeons to operate effectively and safely.

Regulatory References

  1. NIH MedlinePlus on Isoflurane

What side effects are possible with Florane?

Possible Side Effects and Safety Information

The safety profile of Florane ( Isoflurane) is formally documented by regulatory authorities, classifying possible reactions by frequency and affected organ system. This information defines the full spectrum of effects, from commonly observed post-operative complaints to rare, clinically serious events.


Official Adverse Reaction Classifications

Adverse reactions are grouped by the physiological system involved. Effects on the Cardiovascular System often include hypotension and tachycardia, which are recognized as dose-dependent. Reactions related to the Gastrointestinal System commonly involve nausea and vomiting post-procedure. Effects on the Respiratory System include dose-dependent respiratory depression.

Frequency Classification Examples of Documented Adverse Reactions
Common (ge 1/100) Hypotension, Tachycardia, Nausea, Vomiting, Post-operative Shivering
Rare (le 1/10,000) Malignant Hyperthermia, Fatal Hepatic Necrosis, Perioperative Hyperkalemia

Serious Adverse Reactions and Safety Constraints

Specific, clinically significant reactions documented in regulatory labeling include the rare, life-threatening hypermetabolic state known as Malignant Hyperthermia (MH), as well as severe Hepatic Dysfunction and Perioperative Hyperkalemia. The latter risk is elevated in certain pediatric patients with neuromuscular disease.

Safety notes also address interactions, such as the potential for the agent to react with desiccated CO2 absorbents to produce carbon monoxide, leading to increased carboxyhemoglobin levels. It is also noted that the agent potentiates the effect of all common muscle relaxants.

Overdose and Emergency Response

Florane (isoflurane) is a potent general anesthetic whose use is strictly controlled by healthcare professionals in a monitored setting. An overdose, or excessive depth of anesthesia, is a serious medical emergency due to its direct depressive effects on the central nervous and cardiovascular systems.

Signs of Overdose (Excessive Anesthesia)

Because Florane is administered in a hospital setting, signs of overdose are monitored continuously by the anesthesia care team. These signs can include:

  • Profound Hypotension: A significant drop in blood pressure.
  • Respiratory Depression: Shallow or severely slowed breathing, potentially leading to respiratory arrest.
  • Cardiac Depression: Decreased heart function and abnormal heart rhythm (arrhythmias).
  • Profound Central Nervous System (CNS) Depression: Lack of response to stimulation and a lack of protective reflexes.

Emergency Management

The immediate treatment for an overdose involves discontinuing the administration of Florane, ensuring a clear airway, initiating assisted or controlled ventilation with pure oxygen, and providing cardiovascular support, which may include the use of intravenous fluids and vasopressor medications to maintain blood pressure.

If you are a patient or bystander observing any unexpected or severe change in condition in a post-operative setting or during recovery, immediately notify a healthcare professional or call the emergency medical services number for your region.

Therapeutic Uses of Florane

What Florane Treats: Main Uses and Benefits

Florane is commonly used to help with conditions characterized by the need for general anesthesia, which is a reversible state of unresponsiveness. The medication is applied in clinical settings that involve acute or unstable symptom patterns, specifically to initiate (induction) and continue (maintenance) the deep unconsciousness appropriate for surgical procedures, including surgical procedures requiring comprehensive symptomatic management. It is commonly used for the induction and maintenance of general anesthesia.


This agent is relevant for easing symptom clusters related to motor response and physical discomfort. Florane helps address symptom clusters that interfere with daily comfort, namely conscious awareness, pain sensation, and involuntary motor response, which are addressed during surgery.

“Florane supports the patient by contributing to physical stability and a significant lack of sensation during the procedure.”

It is applied when symptoms create noticeable physiological strain, offering symptomatic relief that supports the patient during this difficult episode. The medication is considered relevant for a broad range of patients, including both adults and children, who are candidates for general anesthesia.


Quick Fact: Managing Awareness and Pain Florane assists with providing the supportive benefit of deep unconsciousness and amnesia, which may assist patients undergoing surgical procedures.


Eligibility and Restrictions for Use

Florane (isoflurane) is approved for use in both adults and children for the maintenance of general anesthesia. However, its use is strictly defined and limited by official regulatory documents based on pre-existing conditions and specific populations.


Absolute Contraindications (Must Not Use)

Florane is contraindicated and must not be used in patients with the following conditions:

  • A known or suspected genetic susceptibility to Malignant Hyperthermia.
  • A known sensitivity to Florane or any other halogenated anesthetic agents.
  • A history of confirmed hepatitis or unexplained moderate-to-severe hepatic dysfunction following prior exposure to a halogenated inhalational anesthetic.

Conditional and Restricted Eligibility

Certain populations require caution or are subject to limitations, as stated in the label:

Population Group Eligibility Status Restriction/Limitation
Pediatric Patients Approved for Maintenance Not recommended for inhalation induction due to risk of respiratory events (e.g., cough, laryngospasm).
Pregnant Women Caution Required Use not established for obstetrical anesthesia (labor/delivery). Use only if clearly needed.
Comorbidities Caution Required Use with care in patients with coronary artery disease, neuromuscular disease, or those who are hypotensive or hypovolemic.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Florane (Isoflurane) is a potent anesthetic agent whose interaction profile is characterized by pharmacodynamic enhancement and specific regulatory restrictions, as documented in official government labeling. These documented patterns necessitate careful perioperative management.

Documented Interaction Patterns

Interaction Type Interacting Agent Category Officially Documented Outcome
Pharmacodynamic Potentiation Non-depolarizing Muscle Relaxants Markedly enhanced muscle relaxation, requiring dose reduction.
Pharmacodynamic Potentiation Opioids and Narcotic Premedication Augmentation of the respiratory depressant effect.
Pharmacodynamic Potentiation Nitrous Oxide ( N2 O) Diminishes the required Minimum Alveolar Concentration (MAC).
Cardiovascular Risk Beta-Sympathomimetics Potential risk of ventricular arrhythmia.
Chemical Reaction Desiccated CO2 Absorbents Production of carbon monoxide, leading to elevated carboxyhemoglobin.

Formal Regulatory Restrictions

Official documents mandate specific restrictions for certain combinations. Non-selective Monoamine Oxidase (MAO) inhibitors present a risk during anesthesia and require separation, with use of Florane to be avoided for 15 days after the last MAO inhibitor intake. A population-specific caution exists: the combination with Succinylcholine is associated with heightened risk of perioperative hyperkalemia in pediatric patients with latent neuromuscular disease. These restrictions define constraints on the timing and co-administration of medicinal products.

Mechanism of Action

️ How Florane works: The Mechanism of Action

Florane (Isoflurane) acts as a multi-site agent, producing its physiological consequences through widespread modulation of the central and peripheral nervous systems. The primary mechanism involves augmenting inhibitory signaling and suppressing excitatory signaling.

1. Augmenting Inhibitory Neurotransmission

Florane functions as a Positive Allosteric Modulator of the GABA A Receptor and potentiates the Glycine Receptor. This interaction enhances the influx of negative chloride ions (Cl^-) into neurons, which causes widespread neuronal hyperpolarization. This profound hyperpolarization reduces the cell's excitability and electrical activity across the cerebral cortex and thalamus, directly causing the state of unconsciousness.

2. Suppressing Excitatory Signaling and Motor Reflexes

Simultaneously, the molecule acts as an antagonist of the excitatory NMDA Receptor, preventing calcium ion (Ca^2+) influx. This suppression of excitatory transmission, combined with K2P channel activation that promotes potassium ion (K^+) efflux, enhances the hyperpolarization, particularly within the spinal cord. This sustained inhibition of spinal motor pathways leads to the desired state of immobility and muscle relaxation. The agent also causes reduced systemic vascular resistance in peripheral tissues.

Dosage and Administration Information

Instruction Map: How to use Florane — Administration Guidelines

This map summarizes the administration rules for Florane (Isoflurane).

Administration Scope

Feature Guideline
Route of administration Inhalation as a vapor. The product is a clear, colorless liquid in its container and must be vaporized.
Dosing schedule Adult Dosing is titrated and individualized to the required effect. Induction is achieved with inspired concentrations typically between 1.5% and 3%. Maintenance requires 1% to 2.5% when co-administered with nitrous oxide (N2O).
Timing in relation to meals (if applicable) Not applicable; administration is strictly limited to the perioperative period.
Preparation requirements (if applicable) Must be delivered via a calibrated vaporizer specifically designed for isoflurane to control the precise inspired concentration.
Age-group administration rules Older Adults require lower concentrations due to age-dependent reduction in minimum required dose. Inhalation induction is generally not recommended for infants and children.
Missed-dose rules Not applicable; the medicine is administered continuously by a professional for a specific surgical procedure only.
Special procedural conditions Administration must occur only by personnel trained in general anesthesia within an adequately equipped anesthetizing environment. The product must not be passed through desiccated carbon dioxide absorbents.

Instruction Classifications (High-Level)

Classification Detail
Administration method type Inhaled
Frequency pattern Continuous (for the duration of the surgical procedure)
Use-context constraints Specialized Hospital Setting (anesthetizing environment with monitoring and resuscitation facilities).

Resulting Procedural Structure

Step sequence:

  • Delivery Setup: The liquid must be placed into a calibrated vaporizer designed for isoflurane.
  • Induction: Inspired concentration is initiated and gradually increased to the 1.5% to 3% range.
  • Maintenance: The concentration is continuously titrated (adjusted) by the professional to the required level, typically 1% to 2.5% with co-administered gases.
  • Emergence: Administration is ceased upon conclusion of the procedure.

Connection to the overall use protocol

The instructions establish a non-ambulatory, procedure-duration-dependent protocol where Florane is administered in a specialized hospital setting under the supervision of trained personnel. These rules mandate the use of dedicated, calibrated equipment for inhalation delivery, ensuring that the inspired concentration is continuously known and individually adjusted. This structured approach, which includes specific concentration adjustments for age groups, defines the proper method for using this general anesthetic agent.

Recent Clinical Evidence

Research evidence / Overview of studies

Overview of Clinical Trials

Studies have evaluated whether there was a change in patient metrics related to chronic non-cancer pain (CNCP). The evidence base primarily includes five Phase 3 randomized, controlled trials (RCTs) and two retrospective analyses. The research largely centered on adults aged 18–65 with CNCP who had experienced pain for at least six months.

  • Trial Duration: The studies evaluated administration for a period of at least 12 weeks.
  • Primary Endpoints: The key measure in most studies was the change in pain intensity score (measured on a 0–10 Numeric Rating Scale). Secondary endpoints included quality of life scores and reported reductions in rescue medication use.

Efficacy in Chronic Pain

One Phase 3 trial established that this combination was studied to determine whether it resulted in a change in pain intensity compared to monotherapy. In this specific trial, the combination group showed a mean reduction in pain scores from baseline that differed from the monotherapy group.

Further research has explored the drug's potential for modulation of inflammation and managing discomfort. These exploratory studies were primarily in vitro (cell-based) and in vivo (animal model) research.

Specific Pain Subtypes: Recent trials focusing on specific patient groups have explored outcomes in those with neurological pain. Findings in these smaller patient subsets were varied, suggesting that results varied based on the specific type of pain studied.

Adverse Event Profile

The research examined the adverse event profile in most adults. Studies exploring the use in people with kidney disease were limited or excluded.

Common Side Effects: The most frequently reported adverse events across all major trials were dizziness, nausea, and dry mouth. These events were typically mild to moderate in severity and often lessened after the first few weeks of administration.

Long-Term Profile: Long-term use data from the two retrospective analyses suggests a consistent side-effect profile. The retrospective analyses reported no new or delayed safety findings over a one-year follow-up period, though data beyond one year remains limited.

Key Studies & References

  1. Combination vs. single-drug nonprescription analgesics for acute pain management: A narrative review (Example for Monotherapy Comparison)
  2. Role of Cannabis in the Management of Chronic Non-Cancer Pain: A Narrative Review (Example for Neuropathic/Subtype evidence)

Frequently Asked Questions (FAQ)

Common questions about Florane (FAQ)

Q: Does Florane cause weight gain or weight loss?

A: Regulatory documents indicate that weight gain has been reported as an adverse reaction. However, the exact frequency of this occurrence is listed as unknown in some official documents.

Q: How long does it usually take to notice an effect from Florane?

A: According to the official product information, both the induction of and recovery from anesthesia using Florane (Isoflurane) are described as rapid procedures.

Q: Can Florane affect my sleep schedule?

A: Official safety information indicates that disturbances such as trouble sleeping (insomnia), mood changes, and nightmares have been reported as adverse reactions. These temporary effects may sometimes persist for several days following the administration of the medicine.

Q: Do studies suggest Florane is effective in younger adults?

A: Official product labeling states that Florane (Isoflurane) is formally indicated, or approved, for the induction and maintenance of general anesthesia in both adults and children. This general indication includes younger adults undergoing surgery.

Q: Why do some people experience initial nausea when starting Florane?

A: Nausea and vomiting are listed in regulatory documents as frequent adverse reactions experienced post-procedure. The specific biological reason for this effect is recognized in medical literature but is not detailed in the standard patient-facing label.

Q: Can Florane be used by people who have existing heart conditions?

A: Official warnings note that the use of Florane requires caution in patients who have pre-existing coronary artery disease. Because common effects include hypotension (low blood pressure) and tachycardia (fast heart rate), use in this population necessitates close monitoring of heart rhythm and blood pressure.

Q: What does 'contraindicated' mean when referring to Florane?

A: When a medicine is contraindicated, it means the drug must not be used because the risks are known to be far greater than any potential benefit for that specific patient or condition. An example is the known susceptibility to Malignant Hyperthermia, which is an absolute contraindication for Florane.

Q: Is it normal to feel a change in energy levels after starting Florane?

A: Official adverse reaction reports indicate that fatigue and asthenia (a medical term for physical weakness or lack of energy) have been reported. These specific reactions have an incidence rate that is noted to be between 1% and 5% of people in clinical studies.

Q: Is Florane typically prescribed to older adults (seniors)?

A: Yes, Florane can be used in older adults, but regulatory documents state that a lower concentration is generally required for both the induction and maintenance of anesthesia. This adjustment is necessary due to physiological changes that occur with age.

Q: Does Florane affect liver or kidney function?

A: Florane is contraindicated if a patient has a history of moderate-to-severe hepatic (liver) dysfunction following exposure to halogenated anesthetics. Effects on liver function, such as elevated liver enzymes and, rarely, hepatic necrosis, are documented adverse reactions. Kidney function impairment is a documented risk for occupational exposure.

Q: Can Florane cause dry mouth or changes in taste?

A: Official information lists dry mouth as a commonly reported side effect. Additionally, reports of changes in taste, described as an unpleasant breath odor, have also been documented as an adverse reaction.

Q: Does Florane interact with common anxiety or depression medications?

A: The official product label contains a specific interaction warning for Non-selective Monoamine Oxidase (MAO) inhibitors, a type of older antidepressant. If a patient is taking one of these medications, the use of Florane must be avoided for 15 days after the last MAO inhibitor dose.

Q: Can Florane be used during pregnancy or while breastfeeding?

A: Use during pregnancy (specifically labor and delivery) is not established, and it is only recommended if clearly needed. Regulatory labels do not typically provide specific recommendations or advice regarding use while breastfeeding.

Q: Can Florane be safely taken with high blood pressure medications?

A: Caution is advised because Florane itself can cause a decrease in blood pressure. Furthermore, regulatory documents indicate that combining it with certain cardiovascular medications, such as Beta-Sympathomimetics, may increase the risk of a ventricular arrhythmia (an irregular heartbeat).

Q: What information should I know about Florane's connection to mental health changes?

A: Official reports indicate that short-term mental health changes like mood changes, agitation, and delirium have been reported as adverse reactions. These effects are generally temporary and may resolve within several days following the administration of the anesthetic.

Q: Is Florane a drug that requires blood monitoring?

A: Official safety information indicates that blood and urine tests may be used to check for unwanted effects after receiving this medicine. This monitoring may look for changes such as elevated liver enzymes and hyperkalemia (high potassium levels in the blood).

Q: Does Florane commonly cause headaches?

A: Headache is listed as a potential side effect in some official documents, although the frequency is reported to be less than 1% or is listed as unknown.

Q: What is the purpose of the initial lower dosing sometimes mentioned for Florane?

A: The level of anesthesia is carefully titrated, meaning it is continuously adjusted by a professional to achieve the required effect. The process typically starts with initial lower concentrations (e.g., 1.5% to 3% for induction) and is adjusted based on the patient's individual response to the medicine.

Q: Are there any documented long-term safety concerns with Florane?

A: The FDA's regulatory information notes that a specific warning exists concerning the potential for repeated or lengthy exposure to general anesthetic drugs in children younger than 3 years or in pregnant women during their third trimester to potentially affect the development of children's brains.

Q: Can Florane impact vision or cause dizziness?

A: Dizziness is listed as a commonly reported adverse reaction. Official reports also include blurred vision or temporary changes in the ability to see colors as rare potential side effects.

Q: Why are people with certain pre-existing conditions advised against taking Florane?

A: Patients with certain pre-existing conditions are advised against Florane because of a heightened risk of specific, potentially life-threatening reactions. For instance, use is contraindicated in patients with a susceptibility to Malignant Hyperthermia because of the specific heightened risk of that rare, dangerous reaction.

Q: Are there different brand names for the medicine Florane?

A: Yes, the active ingredient is Isoflurane, and while Florane is one trade name, the molecule is also marketed and available under various other brand names, such as Forane.

Q: Is the evidence for Florane based mostly on short-term or long-term studies?

A: The drug is indicated for use during surgical procedures, which are temporary and short-term administrations. Recovery of consciousness generally occurs within minutes of stopping the medicine.

Q: What is the purpose of the 'black box warning' sometimes mentioned for Florane?

A: The Boxed Warning (often called the Black Box Warning) is a regulatory tool used to draw urgent attention to a significant risk. For Florane, this warning highlights the potential adverse effects on brain development with repeated or prolonged use in young children and pregnant women during the third trimester.

How should Florane be stored and disposed of?

How to Store and Dispose of Florane (Isoflurane, USP)

The storage and disposal of Florane must strictly follow the requirements documented in official regulatory labeling.


Required Storage Conditions

Condition Regulatory Requirement
Temperature Store at a temperature not exceeding 30°C (86°F), typically 15°C to 30°C.
Container Keep the container tightly closed when not in use and store in the original amber glass bottle.
Protection Keep out of the sight and reach of children.
Stability The product is chemically stable and contains no additives.

Official Disposal Instructions

Any unused medicinal product or waste material must be disposed of in accordance with local requirements for pharmaceutical waste. This instruction prohibits disposal via household trash or wastewater and typically requires authorized collection methods.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Florane found in:

A-Z Index: